title: What's our pharmacologic readiness against a bioterrorism attack?
authors.affiliation: Pfizer, Inc, New York, NY, USA.
authors.forename: Kathryn K
authors.initials: KK
authors.lastname: Bucci
authors.forename: Leigh
authors.initials: L
authors.lastname: Briscoe-Dwyer
mesh_terms: D023482:Bioterrorism; D002487:Centers for Disease Control and Prevention, U.S.; D004189:Disaster Planning; D004345:Drug Industry; D006801:Humans; D004364:Pharmaceutical Preparations / Q000600:supply & distribution*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D004364:Pharmaceutical Preparations